| Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer A Murtuza, A Bulbul, JP Shen, P Keshavarzian, BD Woodward, ... Cancer research 79 (4), 689-698, 2019 | 175 | 2019 |
| Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer Y Wang, C Zhao, L Chang, R Jia, R Liu, Y Zhang, X Gao, J Li, R Chen, ... EBioMedicine, 2019 | 68 | 2019 |
| p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single … Y Xie, MA Bulbul, L Ji, CM Inouye, SG Groshen, A Tulpule, DP O’Malley, ... American journal of clinical pathology 141 (4), 593-604, 2014 | 61 | 2014 |
| Desmoplastic Small Round Blue Cell Tumor: A Review of Treatment and Potential Therapeutic Genomic Alterations A Bulbul, BN Fahy, J Xiu, S Rashad, A Mustafa, H Husain, ... Sarcoma 2017, 2017 | 51 | 2017 |
| First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option? A Bulbul, H Husain Frontiers in Oncology 8, 94, 2018 | 33 | 2018 |
| Idiopathic thrombocytopenic purpura and autoimmune neutropenia induced by prolonged use of nivolumab in Hodgkin’s lymphoma A Bulbul, A Mustafa, S Chouial, S Rashad Annals of Oncology 28 (7), 1675-1676, 2017 | 25 | 2017 |
| Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer. A Bulbul, PM Forde, A Murtuza, B Woodward, H Yang, I Bastian, ... Oncology (08909091) 32 (4), 2018 | 17 | 2018 |
| Genomic and Proteomic Alterations in Desmoplastic Small Round Blue-Cell Tumors A Bulbul, JP Shen, J Xiu, P Tamayo, H Husain JCO Precision Oncology, 2018 | 13 | 2018 |
| Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer A Bulbul, A Leal, H Husain Journal of Thoracic Disease 12 (5), 2877-2882, 2020 | 9 | 2020 |
| Epidermal growth factor receptor, excision-repair cross-complementation group 1 protein, and thymidylate synthase expression in penile cancer TB Dorff, AK Schuckman, R Schwartz, S Rashad, A Bulbul, J Cai, J Pinski, ... Clinical genitourinary cancer 14 (5), 450-456. e1, 2016 | 7 | 2016 |
| Vitiligoid hypopigmentation associated with pembrolizumab in metastatic head and neck cancer A Bulbul Oxford Medical Case Reports 2019 (3), omz016, 2019 | 5 | 2019 |
| Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial A Bulbul, E Araujo-Mino Future Oncology 15 (1), 81-94, 2019 | 5 | 2019 |
| Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor. J Xiu, A Bulbul, S Rashad Journal of Clinical Oncology 35 (15_suppl), 11066-11066, 2017 | 5 | 2017 |
| Opioid dose reduction and pain control with medical cannabis. A Bulbul, EA Mino, M Khorsand-Sahbaie, L Lentkowski Journal of Clinical Oncology 36 (34_suppl), 189-189, 2018 | 4 | 2018 |
| Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation A Bulbul Oxford Medical Case Reports 2018 (9), omy066, 2018 | 4 | 2018 |
| The conundrum of adjuvant HER2 treatment options A Bulbul, E Araujo-Mino, ZR Dayao Frontiers in oncology 8, 177, 2018 | 2 | 2018 |
| Alternate Day Oral Iron Dosing in Iron Deficiency Anemia A Bulbul, E Araujo Mino, V Dake, A Bautista, L Lentkowski, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 1 | 2018 |
| Immunogenic cell death: chemoimmunotherapy in the clinic A Bulbul Trends in Immunotherapy 2 (1), 2018 | 1 | 2018 |
| Treatment, logistical, and cost burden of prior authorization in community practice. A Bulbul, M Huber, S Rashad, EA Mino, A Bautista, P Salcido, J Marquez, ... Journal of Clinical Oncology 35 (31_suppl), 164-164, 2017 | 1 | 2017 |
| EGFR, TS, and ERCC1 expression in penile squamous cancer (PSC). TB Dorff, R Schwartz, Y Ma, J Cai, A Bulbul, EC Skinner, DI Quinn, ... Journal of Clinical Oncology 29 (7_suppl), 219-219, 2011 | 1 | 2011 |
Fernando J Lopez DiazNeogenomics LaboratoriesVerified email at neogenomics.com
